RARA CRAFT DATABASE for FDA Medical Devices
510(k)K203395

FDA DEVICE FACTS

Platform treatment system

Shanghai Apolo Medical Technology Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 28, 2022PRODUCT CODEGEX

Indications for use

The Platform Treatment System can be used in dermatology, cosmetic surgery, and other surgical applications according to the different hand pieces. The specific indications should reference to the indications of each hand piece.

1) IPL Handpiece

- Permanent hair reduction- long-term stable reduction in number of hairs re-growing after a treatment regimen;

- Moderate inflammatory acne vulgaris;

- Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, ephelides (freckles);

- Cutaneous lesions including scars;

- Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial truncal and leg telangiectasias, erythema of rosacea, leg veins, spider angiomas and venous malformations. (2) Q-s witched Nd:YAG laser Handpiece (1064nm wavelength):

- Benign vascular and pigmented lesions, age spots;

- Nevus spilus;

- Tattoo removal. (3) Long pul sed Nd:YAG Handpiece:

- Benign vascular lesions

- Superficial and deep telangiectasias (venulectasias)

- Benign cutaneous lesions

- Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.

- The non-ablative treatment of facial wrinkles

- Laser skin resurfacing procedures

- Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.

- Indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.

- Removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles.

- Removal or lightening of unwanted hair (with and without adjuvant preparation)

- Treatment of pseudofolliculitis barbae (PFB)

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026